Universal Health Services, Inc.
UHS Healthcare Medical - Care Facilities NYSE
$231.08
+$0.49 (+0.21%)
Open: $232.87 | High: $232.87 | Low: $229.60 | Prev Close: $230.59
Market Cap: $14.90B
Volume: 322K | Avg: 663K
Last updated: December 05, 2025 at 10:07 PMInvestment Rating
Buy
Overall Score: 80/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 590
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 11.00 |
| P/B Ratio | 2.06 |
| P/S Ratio | 0.88 |
| EPS | $21.01 |
| Beta | 1.29 |
| Shares Outstanding | 64.47M |
| 52-Week High | $246.33 |
| 52-Week Low | $152.33 |
| SMA 50 | $217.95 |
| SMA 200 | $188.93 |
| Dividend Yield | 0.35% |
| Annual Dividend | $0.80 |
| Next Earnings | February 25, 2026 05:00 AM ET |
Financial Ratios
| Gross Margin | 90.3% |
| Operating Margin | 11.5% |
| Net Margin | 8.1% |
| ROE | 19.9% |
| ROA | 9.0% |
| Debt/Equity | 0.71 |
| Current Ratio | 1.03 |
| Quick Ratio | 0.96 |
Balance Sheet
| Total Assets | $14.47B |
| Total Liabilities | $7.71B |
| Total Equity | $6.67B |
| Cash | $125.98M |
| Total Debt | $4.96B |
| Net Debt | $4.83B |
Income Statement
| Revenue | $15.83B |
| Gross Profit | $14.24B |
| Operating Income | $1.68B |
| Net Income | $1.14B |
| EBITDA | $2.27B |
| Revenue/Share | $264.04 |
Cash Flow
| Operating CF | $2.07B |
| CapEx | $943.81M |
| Free Cash Flow | $1.12B |
| Book Value/Share | $113.39 |
| Tangible Book/Share | $51.40 |
| Equity/Share | $112.35 |
Technical Indicators
| RSI (14) | 53.51 Neutral |
| MACD |
5.52
Signal: 6.55
|
| Volatility | 27.62% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | +25.98% |
| Sharpe Ratio | 0.87 Fair |
| Volatility (Ann.) | 34.73% Moderate |
| UHS (1Y) | +25.98% |
| S&P 500 (1Y) | +11.86% |
| Alpha (Excess Return) | +14.12% |
Sector Comparison (Healthcare)
| Metric | UHS | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 11 | 31.55 | 12% |
| P/B Ratio | 2.06 | -0.59 | 33% |
| ROE (%) | 19.85% | 9.63% | 65% |
| Net Margin (%) | 8.09% | 10.08% | 35% |
| Stock Score | 590 | 503.0 | 92% |
| 1Y Return (%) | +25.98% | +4.05% | 83% |
Historical Price Analysis (Last 200 Days)
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UHS | $231.08 | $236.50 | $238.42 | $234.46 | $217.95 | $188.93 | 53.51 | 5.52 | 27.62% | 475638 | Weak Short | Price Below SMAs |
Candlestick Patterns
There wasn't any recognizable pattern for the UHS stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| UHS | UNIVERSAL HEALTH SERVICES INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Universal Health Services's Directors and Officers for Breach of Fiduciary Duties – UHS | Neutral | businesswire.com | Read More |
| UHS | KMT, UHS, and More Are Now Strong Buy Stocks (Dec. 3) | Neutral | zacks.com | Read More |
| UHS | Best Growth Stocks to Buy for Dec.3 | Positive | zacks.com | Read More |
| UHS | Best Value Stocks to Buy for Dec. 3 | Neutral | zacks.com | Read More |
| UHS | Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term | Neutral | zacks.com | Read More |
Company Information
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
| CEO | Marc D. Miller |
| Employees | 99300 |
| Country | US |
| IPO Date | 1981-07-09 |
| Exchange | NYSE |
| Website | https://uhs.com |
| Sector | Healthcare |
| Industry | Medical - Care Facilities |
Similar Stocks (Healthcare - Medical - Care Facilities)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category